Adeofarma
Adeofarma UAB is a Vilnius-based pharmaceutical services and distribution partner representing the portfolios of six international pharma principals (ROVI, ASAC, ANFARM, LAPHYSAN, PANPHARMA, ROMPHARM) across the Baltic states, providing regulatory affairs, pharmacovigilance, supply chain, and market access services focused on hospital lines.
- Company typePrivate
- Founded2013
- HeadquartersVilnius, Lithuania
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Adeofarma does
Adeofarma UAB is a private Lithuanian pharmaceutical services and distribution intermediary founded in 2013 and headquartered in Vilnius, with a branch opened in Latvia in 2024. The firm operates across the three Baltic states (Lithuania, Latvia, Estonia), holding a Wholesale Distribution Licence (2014), a Good Distribution Practice certificate (2018), and a narcotics licence (2022) that together authorize it to distribute hospital pharmaceuticals and controlled substances. It represents the portfolios of six international pharma principals — ROVI, ASAC, ANFARM, LAPHYSAN, PANPHARMA, and ROMPHARM — focused primarily on hospital lines and non-registered products, while also providing standalone regulatory affairs, pharmacovigilance, supply chain, sales and marketing, and market access services to pharma clients seeking Baltic entry.
The underlying technology is a service operating model rather than a software platform: workflows span marketing authorization filings and variations, adverse-drug-reaction reporting via a dedicated pharmacovigilance inbox, end-to-end physical supply chain (collecting, storage, packing, delivering), and sales/promotion tracking. The company also operates international sales of pharmaceuticals, aesthetics, and cosmetics under a sister brand (adeoaesthetic.com), plus clinical trial supply sourcing and distribution, and consultancy covering batch release, in/out licensing, and business development. No proprietary software, AI tooling, or API products are disclosed.
Revenue mechanics combine transaction-fee economics on represented partner portfolios (channel/distributor model) with professional-services fees for regulatory, pharmacovigilance, and consulting engagements. The customer base is B2B and enterprise — international pharma manufacturers seeking Baltic market access — with a small team of approximately five to ten people delivering a full-lifecycle service suite that would typically require a larger organization in larger markets.
Adeofarma firmographics
Firmographics- Name
- Adeofarma
- Legal name
- UAB "Adeofarma"
- Website
- https://adeofarma.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Adeofarma UAB is a Vilnius-based pharmaceutical services and distribution partner representing the portfolios of six international pharma principals (ROVI, ASAC, ANFARM, LAPHYSAN, PANPHARMA, ROMPHARM) across the Baltic states, providing regulatory affairs, pharmacovigilance, supply chain, and market access services focused on hospital lines.
- Ownership category
- akta.pro rank
Adeofarma industry classification
Industry- Product category
- Pharmaceutical Distribution Services
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA)
- akta.pro secondary industries
- Controlled Substances & Compliance-Focused Pharmaceutical Distributors (HLAIAJAN), Channel/Partner Sales Support (Reseller Enablement, Deal Reg) (BPAAADAH), Pharmacy Logistics, Returns, Reverse Distribution & Compliance Services (CRAOAHAJ)
Keywords
Where Adeofarma is headquartered
LocationHeadquarters
- HQ city
- Vilnius
- HQ country
- Lithuania
- HQ region
- Europe
Offices2 records
Markets served
Adeofarma business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Marketing or Sales, Others
Revenue model
- Portfolio Representation: Representing pharmaceutical partner portfolios (ROVI, ASAC, ANFARM, LAPHYSAN, PANPHARMA, ROMPHARM) for distribution in Lithuania, Latvia, and Estonia. Main focus on hospital lines and non-registered pharmaceuticals.
- Regulatory Affairs & Pharmacovigilance Services: Providing regulatory affairs services (marketing authorizations, translations, variations, renewals) and pharmacovigilance services (scientific service, individual case safety reports, product safety profile, regulatory intelligence) to pharmaceutical clients.
- International Sales: International sales of pharmaceuticals, aesthetics, and cosmetics. Clinical trial supply sourcing and distribution. Consultancy services including batch release, in/out licensing, and business development.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels1 record
Adeofarma product offering
Product offeringCore offering
Adeofarma delivers pharmaceutical wholesale distribution together with regulatory affairs, pharmacovigilance, supply chain management, sales and marketing, and market access services to international pharmaceutical partners across the Baltic states. The company serves as an end-to-end partner that handles market entry, ongoing compliance, and commercial sales of partner pharmaceutical portfolios in Lithuania, Latvia, and Estonia.
Product overview
Adeofarma is a pharmaceutical services company offering a comprehensive suite of interconnected services across the entire pharmaceutical lifecycle. The company operates as a single integrated offering rather than separate modular products—its services span regulatory affairs (marketing authorizations, translations, variations, renewals), pharmacovigilance (safety reporting and regulatory intelligence), portfolio management (analysis, strategy, selection, development), supply chain management (collecting, storage, packing, delivering), sales and marketing, and market access (pricing and reimbursement). Beyond the Baltic region, Adeofarma provides international sales services for pharmaceuticals, aesthetics, and cosmetics, along with clinical trials supply and consultancy services including batch release, licensing, and business development. The company focuses primarily on hospital lines and non-registered pharmaceuticals.
Differentiator
Problem solved
Functional benefit
Products and services
- Regulatory Affairs Services
- Pharmacovigilance Services Ongoing pharmacovigilance and adverse drug reaction (ADR) monitoring and reporting for partner pharmaceutical portfolios in the Baltic region. Built on dedicated pharmacovigilance and ADR reporting systems.
- Portfolio Management Lifecycle management of partner pharmaceutical portfolios in the Baltic market, coordinating regulatory, supply, and commercial activities across the product range.
- Supply Chain Management End-to-end pharmaceutical supply chain management across the Baltic states, leveraging GDP certification, Wholesale Distribution Licence, and narcotics handling capability.
- Sales and Marketing Services Sales and marketing execution for partner pharmaceutical products in the Baltic region, including promotion to hospital and pharmacy channels.
- Market Access Services Market access support helping partner pharmaceutical manufacturers obtain reimbursement, listing, and uptake of their products in Baltic health systems.
- International Sales International sales representation for partner pharmaceutical companies, including the management of an existing portfolio of international partner manufacturers.
- Clinical Trials Supply Licensed supply of pharmaceutical products, including investigational and controlled substances, to clinical trial sites in the Baltic region.
- Consultancy Services Advisory and consulting services covering regulatory, market access, and commercial topics for pharmaceutical manufacturers evaluating or operating in the Baltic market.
Companies that use Adeofarma
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles2 records
Adeofarma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Adeofarma partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core.
- ROVIcoreROVI is a pharmaceutical partner whose portfolio is represented by Adeofarma in Lithuania, Latvia, and Estonia. Focus on hospital lines and non-registered pharmaceuticals.
- ASACcoreASAC is a pharmaceutical partner whose portfolio is represented by Adeofarma in Lithuania, Latvia, and Estonia. Focus on hospital lines and non-registered pharmaceuticals.
- ANFARMcoreANFARM is a pharmaceutical partner whose portfolio is represented by Adeofarma in Lithuania, Latvia, and Estonia. Focus on hospital lines and non-registered pharmaceuticals.
- LAPHYSANcoreLAPHYSAN is a pharmaceutical partner whose portfolio is represented by Adeofarma in Lithuania, Latvia, and Estonia. Focus on hospital lines and non-registered pharmaceuticals.
- PANPHARMAcorePANPHARMA is a pharmaceutical partner whose portfolio is represented by Adeofarma in Lithuania, Latvia, and Estonia. Focus on hospital lines and non-registered pharmaceuticals.
- ROMPHARMcoreROMPHARM is a pharmaceutical partner whose portfolio is represented by Adeofarma in Lithuania, Latvia, and Estonia. Focus on hospital lines and non-registered pharmaceuticals.
Scale indicators3 records
Recent moves7 records
Expansion highlights5 records
Adeofarma competitors and assessment
Company assessmentDirect peers
- MAGNUM MEDICAL: Magnum Medical is a Baltic-focused distributor of pharmaceuticals, medical devices, and consumables across Lithuania, Latvia, and Estonia. It is directly comparable in geographic footprint and channel-partner role to Adeofarma.
- Tamro (Phoenix Group): Tamro is the largest pharmaceutical wholesaler in the Baltic states (Lithuania, Latvia, Estonia) under Phoenix Group. It is the most direct competitor to Adeofarma's wholesale and distribution business in the same three-country footprint.
Broad incumbents
- ProPharma Group: ProPharma Group provides regulatory compliance, pharmacovigilance, and quality assurance consulting to pharma and biotech clients. It competes with Adeofarma's regulatory affairs and pharmacovigilance offerings for the same manufacturer customer base.
- IQVIA: IQVIA is a global leader in pharma services including market access, regulatory, and commercialization support. It addresses the same manufacturer pain points (market access, pricing/reimbursement, regulatory) that Adeofarma targets, but at vastly greater scale and breadth.
- PharmaLex (Cencora): PharmaLex, now part of Cencora, is a global provider of regulatory affairs, pharmacovigilance, and market access consulting to pharma manufacturers. It offers the same regulatory/pharmacovigilance service lines that Adeofarma provides, but at global scale.
Regional players
- Euroapotheca: Euroapotheca operates one of Lithuania's largest pharmacy chains and is part of the broader Baltic retail-pharmacy ecosystem. It is a downstream buyer of pharma distribution services and represents the type of customer channel Adeofarma serves in Lithuania.
- Sopharma Trading: Sopharma Trading is a pharmaceutical wholesaler and distributor serving Central/Eastern Europe. While not active in the Baltics, it is a comparable regional pharma distribution and services model outside Western Europe.
Emerging players
- ClinChoice: ClinChoice is a CRO/regulatory services firm offering clinical trial supply, regulatory affairs, and pharmacovigilance. It overlaps with Adeofarma's clinical trials supply and regulatory services but operates at larger global scale.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Adeofarma social profiles
Digital presenceAdeofarma compliance and trust
Trust signalCompliance2 records
Adeofarma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Adeofarma leadership team
Management profileNumber of profiles
Adeofarma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Adeofarma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Adeofarma
What does Adeofarma do?
Adeofarma delivers pharmaceutical wholesale distribution together with regulatory affairs, pharmacovigilance, supply chain management, sales and marketing, and market access services to international pharmaceutical partners across the Baltic states. The company serves as an end-to-end partner that handles market entry, ongoing compliance, and commercial sales of partner pharmaceutical portfolios in Lithuania, Latvia, and Estonia.
Is Adeofarma a public or private company?
Adeofarma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Adeofarma founded?
Adeofarma was founded in 2013. It employs 1 to 10 people.
Where is Adeofarma based?
Adeofarma is headquartered in Vilnius, Lithuania, in the Europe region.
How does Adeofarma make money?
Three revenue lines are on record. Portfolio Representation is the primary driver. The others are regulatory Affairs & Pharmacovigilance Services and international Sales.
Who are Adeofarma's main competitors?
Direct peers on record are MAGNUM MEDICAL and Tamro (Phoenix Group). Broad incumbents are ProPharma Group, IQVIA and PharmaLex (Cencora). Regional players are Euroapotheca and Sopharma Trading. ClinChoice is listed as an emerging player.
Does Adeofarma have an API?
No public API is recorded for Adeofarma.
What industry is Adeofarma in?
Adeofarma's product category is Pharmaceutical Distribution Services. Its primary akta.pro industry code is CRAOAHAA, Prescription Pharmaceutical (Rx) Wholesale Distribution, with a secondary code of HLAIAJAN, Controlled Substances & Compliance-Focused Pharmaceutical Distributors. Its NAICS code is 424210 and its SIC code is 5122.